Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa
Abstract Background HIV endpoint-driven clinical trials increasingly provide oral pre-exposure prophylaxis (PrEP) as standard of prevention during the trial, however, among participants desiring to continue using PrEP at trial exit, little is known about post-trial PrEP access and continued use. Met...
Main Authors: | Ivana Beesham, Cecilia Milford, Jenni Smit, Dvora L. Joseph Davey, Jared M. Baeten, Renee Heffron, Mags Beksinska, Leila E. Mansoor |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-06-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12889-023-16139-z |
Similar Items
-
Uptake of Contraception Among Adolescent Girls and Young Women PrEP Clients: Leveraging the Opportunity to Strengthen HIV and Sexual and Reproductive Health Integration
by: Melanie Pleaner, et al.
Published: (2021-07-01) -
Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa
by: Nehaa Khadka, et al.
Published: (2023-09-01) -
Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women
by: Maria Pyra, et al.
Published: (2019-04-01) -
Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial
by: Dvora Leah Joseph Davey, et al.
Published: (2022-07-01) -
Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study
by: Dvora Joseph Davey, et al.
Published: (2022-12-01)